Title |
A core microbiome associated with the peritoneal tumors of pseudomyxoma peritonei
|
---|---|
Published in |
Orphanet Journal of Rare Diseases, July 2013
|
DOI | 10.1186/1750-1172-8-105 |
Pubmed ID | |
Authors |
Jeremy J Gilbreath, Cristina Semino-Mora, Christopher J Friedline, Hui Liu, Kip L Bodi, Thomas J McAvoy, Jennifer Francis, Carol Nieroda, Armando Sardi, Andre Dubois, David W Lazinski, Andrew Camilli, Traci L Testerman, D Scott Merrell |
Abstract |
Pseudomyxoma peritonei (PMP) is a malignancy characterized by dissemination of mucus-secreting cells throughout the peritoneum. This disease is associated with significant morbidity and mortality and despite effective treatment options for early-stage disease, patients with PMP often relapse. Thus, there is a need for additional treatment options to reduce relapse rate and increase long-term survival. A previous study identified the presence of both typed and non-culturable bacteria associated with PMP tissue and determined that increased bacterial density was associated with more severe disease. These findings highlighted the possible role for bacteria in PMP disease. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 3 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Germany | 1 | 1% |
Belgium | 1 | 1% |
Unknown | 68 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 17 | 24% |
Student > Ph. D. Student | 9 | 13% |
Other | 6 | 9% |
Student > Master | 6 | 9% |
Student > Bachelor | 5 | 7% |
Other | 18 | 26% |
Unknown | 9 | 13% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 12 | 17% |
Agricultural and Biological Sciences | 11 | 16% |
Biochemistry, Genetics and Molecular Biology | 9 | 13% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 7% |
Engineering | 4 | 6% |
Other | 12 | 17% |
Unknown | 17 | 24% |